EUK 207

01/01/2017 - "Mitigating effect of EUK-207 on radiation-induced cognitive impairments."
01/01/2012 - "Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline."

11/01/2012 - "After TBI, morbidity and the increase in breathing rates associated with pneumonitis were significantly improved in rats treated with EUK-207 compared to rats receiving irradiation alone. "
11/01/2012 - "At 42 days after TBI (the peak of pneumonitis) changes in vascular end points including pulmonary hemodynamics ex vivo and relative arterial density in lungs were also mitigated by EUK-207. "
02/01/2013 - "We demonstrated that both genistein and EUK-207 delayed and suppressed the increased breathing rate associated with pneumonitis. "
11/01/2012 - "Short-term treatment with a SOD/catalase mimetic, EUK-207, mitigates pneumonitis and fibrosis after single-dose total-body or whole-thoracic irradiation."
11/01/2012 - "The superoxide dismutase and catalase mimetic EUK-207 was given by subcutaneous injection (20 mg/kg/day, 5 days per week, once daily) starting at 7 days after irradiation and stopping before pneumonitis developed. "

11/01/2012 - "Our results demonstrate promise for EUK-207 as a mitigator of radiation pneumonitis and fibrosis. "

11/01/2012 - "Our results demonstrate promise for EUK-207 as a mitigator of radiation pneumonitis and fibrosis. "
11/01/2012 - "Short-term treatment with a SOD/catalase mimetic, EUK-207, mitigates pneumonitis and fibrosis after single-dose total-body or whole-thoracic irradiation."

01/01/2012 - "Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline."